Detection of Escherichia coli 16S RNA and Cytotoxic Necrotizing Factor 1 Gene in Benign Prostate Hyperplasia

European Urology

Volumn 51, Issue 2, 2007, Pages 457-463

  Bergh, Johanna ^a   Marklund, Ingrid ^a   Thellenberg Karlsson, Camilla ^a   Grönberg, Henrik ^b   Elgh, Fredrik ^a   Alexeyev, Oleg A ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Benign prostate hyperplasia; Cytotoxic necrotizing factor; Escherichia coli

Indexed keywords

ALPHA HEMOLYSIN; AUTOTRANSPORTED PROTEIN; BACTERIAL RNA; CYTOTOXIC NECROTIZING FACTOR 1; FIMBRIA PROTEIN; PROTEIN;

ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; GENE; GENOTYPE; HUMAN; HUMAN TISSUE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NECROSIS; PRIORITY JOURNAL; PROSTATE; PROSTATE HYPERTROPHY; SAMPLE; TRANSURETHRAL RESECTION;

AGED; BACTERIAL TOXINS; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; HUMANS; MALE; MIDDLE AGED; PROSTATIC HYPERPLASIA; RETROSPECTIVE STUDIES; RNA, RIBOSOMAL, 16S;

EID: 33845574594     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2006.06.008     Document Type: Article

References (20)

1. Oelschlaeger T.A., Dobrindt U., and Hacker J. Virulence factors of uropathogens. Curr Opin Urol 12 (2002) 33-38
2. Andreu A., Stapleton A.E., Fennell C., et al. Urovirulence determinants in Escherichia coli strains causing prostatitis. J Infect Dis 176 (1997) 464-469
3. Mitsumori K., Terai A., Yamamoto S., Ishitoya S., and Yoshida O. Virulence characteristics of Escherichia coli in acute bacterial prostatitis. J Infect Dis 180 (1999) 1378-1381
4. Ruiz J., Simon K., Horcajada J.P., et al. Differences in virulence factors among clinical isolates of Escherichia coli causing cystitis and pyelonephritis in women and prostatitis in men. J Clin Microbiol 40 (2002) 4445-4449
5. Terai A., Yamamoto S., Mitsumori K., et al. Escherichia coli virulence factors and serotypes in acute bacterial prostatitis. Int J Urol 4 (1997) 289-294
6. Rippere-Lampe K.E., Lang M., Ceri H., Olson M., Lockman H.A., and O'Brien A.D. Cytotoxic necrotizing factor type 1-positive Escherichia coli causes increased inflammation and tissue damage to the prostate in a rat prostatitis model. Infect Immun 69 (2001) 6515-6519
7. Bedalov G., Vuckovic I., Fridrih S., Bruk M., Puskar D., and Bartolin Z. Prostatitis in benign prostatic hyperplasia: a histological, bacteriological and clinical study. Acta Med Croatica 48 (1994) 105-109
8. Greer C.E., Wheeler C.M., and Manos M.M. Sample preparation and PCR amplification from paraffin-embedded tissues. PCR Methods Appl 3 (1994) S113-S122
9. Harris K.A., and Hartley J.C. Development of broad-range 16S rDNA PCR for use in the routine diagnostic clinical microbiology service. J Med Microbiol 52 (2003) 685-691
10. Welch R.A., Burland V., Plunkett III G., et al. Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc Natl Acad Sci U S A 99 (2002) 17020-17024
11. Falbo V., Pace T., Picci L., Pizzi E., and Caprioli A. Isolation and nucleotide sequence of the gene encoding cytotoxic necrotizing factor 1 of Escherichia coli. Infect Immun 61 (1993) 4909-4914
12. De Groote D., Haesebrouck F., van Doorn L.J., Vandamme P., and Ducatelle R. Evaluation of a group-specific 16S ribosomal DNA-based PCR for detection of Helicobacter bizzozeronii, Helicobacter felis, and Helicobacter salomonis in fresh and paraffin-embedded gastric biopsy specimens. J Clin Microbiol 39 (2001) 1197-1199
13. Fredricks D.N., Fiedler T.L., and Marrazzo J.M. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med 353 (2005) 1899-1911
14. Weidner W., Schiefer H.G., Krauss H., Jantos C., Friedrich H.J., and Altmannsberger M. Chronic prostatitis: a thorough search for etiologically involved microorganisms in 1,461 patients. Infection 19 (1991) S119-S125
15. Gorelick J.I., Senterfit L.B., and Vaughan Jr. E.D. Quantitative bacterial tissue cultures from 209 prostatectomy specimens: findings and implications. J Urol 139 (1988) 57-60
16. Nickel J.C., Downey J., Young I., and Boag S. Asymptomatic inflammation and/or infection in benign prostatic hyperplasia. BJU Int 84 (1999) 976-981
17. Genster H.G., and Madsen P.O. Urinary tract infections following transurethral prostatectomy: with special reference to the use of antimicrobials. J Urol 104 (1970) 163-168
18. Johnson J.R., Kuskowski M.A., Gajewski A., et al. Extended virulence genotypes and phylogenetic background of Escherichia coli isolates from patients with cystitis, pyelonephritis, or prostatitis. J Infect Dis 191 (2005) 46-50
19. Shiina H., Himeno Y., and Ishibe T. Organisms in the prostate and antibiotics in the treatment of postoperative infections. Urol Int 48 (1992) 187-190
20. Madersbacher S., Alivizatos G., Nordling J., Sanz C.R., Emberton M., and de la Rosette J.J. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol 46 (2004) 547-554